PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.\', \'Emergency Department, University Hospital Basel, Basel, Switzerland.\', \'Service of Haematology, Clinica Luganese Moncucco, Lugano, Switzerland.\', \'Department of Cardiology, Inselspital Bern, University of Bern, Bern, Switzerland.\', \'Clinic of Haematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.\', \'Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.\', \'Cardiology Division, Geneva University Hospital, Geneva, Switzerland.\', \'Department of Angiology, Lausanne University Hospital, Lausanne, Switzerland.\', \'Division of Angiology and Haemostasis, Department of Medical Specialties, Geneva University Hospital, Geneva, Switzerland.\', \'Institute of Primary Care, University of Zurich, Zurich, Switzerland.\', \'Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland. nils.kucher@usz.ch.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04678-4
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32907635
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all